AstraZeneca PLCAZNNASDAQ
Loading
Dividends/Share Growth Under PressureDecelerating
Percentile Rank49
Year-over-Year Change
Year-over-year dividends per share growth
Latest
-99.22%
↓ 101% vs avg
Percentile
P49
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
7307.25%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -99.22% |
| Q3 2025 | 15786.73% |
| Q2 2025 | -99.70% |
| Q1 2025 | 111466.67% |
| Q4 2024 | -99.81% |
| Q3 2024 | 9170.59% |
| Q2 2024 | -99.44% |
| Q1 2024 | 151550.00% |
| Q4 2023 | -99.86% |
| Q3 2023 | 6313.23% |
| Q2 2023 | -99.28% |
| Q1 2023 | 0.00% |
| Q4 2022 | -100.00% |
| Q3 2022 | 0.00% |
| Q2 2022 | -100.00% |
| Q1 2022 | 0.00% |
| Q4 2021 | -100.00% |
| Q3 2021 | 0.00% |
| Q2 2021 | -100.00% |
| Q1 2021 | 0.00% |
| Q4 2020 | -100.00% |
| Q3 2020 | 0.00% |
| Q2 2020 | -100.00% |
| Q1 2020 | 0.00% |
| Q4 2019 | -100.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | -100.00% |
| Q1 2019 | 0.00% |
| Q4 2018 | -100.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | -100.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | -100.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | -100.00% |
| Q1 2017 | 0.00% |
| Q4 2016 | -100.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | -100.00% |
| Q1 2016 | 0.00% |